EHR

Trella Health Unveils its 2024 Post-Acute Care Industry Trend Report

A comprehensive analysis of key trends, challenges, and opportunities driving the evolution of post-acute care. ATLANTA, July 18, 2024 /PRNewswire/…

2 years ago

Global Health Information Exchange Market: USD 2.8B Projection, USD 1.7B Base, 10.2% CAGR | MarketsandMarkets™

CHICAGO, July 18, 2024 /PRNewswire/ -- The global Health Information Exchange market is poised for significant growth, projected to reach…

2 years ago

Eyenuk Appoints Bryan Haardt as Chief Executive Officer

Haardt brings decades of digital healthcare experience to build on Eyenuk's global mission of using AI to detect and prevent…

2 years ago

Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer’s biosimilar to Humira®

First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18,…

2 years ago

Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery

‘Breaking Barriers’ Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting…

2 years ago

First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones

Boehringer_Workplace_Lab_Research Media image Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncologyFurther data read-outs expected in 2024 in oncology,…

2 years ago

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and…

2 years ago

Q2 2024 Revenue and Business Highlights, Guidance Upgrade

MELBOURNE, Australia, July 18, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update…

2 years ago

Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease

The project will evaluate the real-world impact of Brainomix's e-Lung imaging software to improve the identification and access to treatment for…

2 years ago